.png)
RETATRUTIDE
Retatrutide is a synthetic peptide that acts as a multi-receptor agonist targeting glucagon (GCGR), glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptors. It is used in scientific research to study integrated metabolic signaling and energy balance pathways. This compound is utilized in laboratory settings to investigate mechanisms related to glucose regulation, hormone signaling, and metabolic function. It is intended strictly for research purposes and is not approved for human or veterinary use outside of regulated clinical applications.
Research Applications
Multi-Receptor Metabolic Signaling
Retatrutide is used to study combined activation of GLP-1, GIP, and glucagon receptors. This multi-agonist approach allows researchers to investigate complex metabolic signaling interactions and pathway integration.
Sources:
Glucose Regulation & Insulin Dynamics
Research involving Retatrutide examines its effects on glucose homeostasis, insulin secretion, and glucagon signaling in experimental models of metabolic regulation.
Sources:
Energy Expenditure & Metabolic Pathways
Retatrutide is utilized in studies exploring energy balance, including pathways related to energy expenditure and nutrient utilization through multi-hormonal receptor activity.
Sources:
Endocrine System Integration
The compound is applied in research examining how multiple hormonal systems interact, particularly within pancreatic, hepatic, and gastrointestinal signaling networks.
Sources:
